knowledge -WSS

knowledge

author：explore 2025-10-06 08:57:18 - browse：6

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Johnson & Johnson sues to stop Medicare negotiation

leisure time

WSS

Johnson & Johnson sues to stop Medicare negotiation

There’s a way to spot data fakery. All journals should be using it

Johnson & Johnson sues to stop Medicare negotiation

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

FDA seeking to stop procedures at two unregulated stem cell clinics

A new ‘biological computer' targets cancer while sparing healthy cells

focus

knowledge

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Caribou posts encouraging results on off

In age of alternative facts, a scholarly course on calling out crap

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Moonlake's readout produced a cash windfall. Risks remain

The stock market has soared this year, but will it last? Experts weigh in

How to save PrEP access — and even expand it

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Supreme Court strikes down use of affirmative action

Delta passengers in Vegas fall sick while waiting on flight in triple

hotspot

Scientists grapple with ethics of stem cell research

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

More hospitals are billing patients as online messages surge

A new ‘biological computer' targets cancer while sparing healthy cells

Dementia risk linked to living in disadvantaged areas: Study

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

leisure time

focus

hotspot

knowledge